-
Income Statement
-
Balance Sheet
-
Cashflow Statement
-
Profitability
-
Ratios
The Procter & Gamble Company Income Statement
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Revenue |
|
$70.95B | $76.12B | $80.19B | $82.01B | $84.04B |
| Cost of Revenue |
|
$35.25B | $37.11B | $42.16B | $42.76B | $40.60B |
| Gross Profit |
|
$35.70B | $39.01B | $38.03B | $39.25B | $43.44B |
| Research & Development |
|
$1.80B | $1.90B | $2.00B | $2.00B | $2.00B |
| Selling,General & Administrative |
|
$19.99B | $21.02B | $20.22B | $21.11B | $23.31B |
| Operating Expense |
|
$19.99B | $21.02B | $20.22B | $21.11B | $24.89B |
| Operating Income |
|
$15.71B | $17.99B | $17.81B | $18.13B | $18.55B |
| Net Income |
|
$13.03B | $14.31B | $14.74B | $14.65B | $14.88B |
The Procter & Gamble Company Balance Sheet
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Cash and Cash Equivalents |
|
$16.18B | $10.29B | $7.21B | $8.25B | $9.48B |
| Inventories |
|
$5.50B | $5.98B | $6.92B | $7.07B | $7.02B |
| Total Current Assets |
|
$27.99B | $23.09B | $21.65B | $22.65B | $24.71B |
| Property,Plant and Equipment |
|
$20.69B | $21.69B | $21.20B | $21.91B | $23.03B |
| Goodwill |
|
$39.90B | $40.92B | $39.70B | $40.66B | $40.30B |
| Total Assets |
|
$120.70B | $119.31B | $117.21B | $120.83B | $122.37B |
| Total Liabilities |
|
$73.82B | $72.65B | $70.35B | $73.76B | $71.81B |
| Retained Earnings |
|
$100.24B | $106.37B | $112.43B | $118.17B | $123.81B |
| Total Shareholder Equity |
|
$46.52B | $46.38B | $46.59B | $46.78B | $50.29B |
| Common Stock |
|
$4.01B | $4.01B | $4.01B | $4.01B | $4.01B |
The Procter & Gamble Company Cash flow
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Depreciation & Amortization |
|
$3.01B | $2.74B | $2.81B | $2.71B | $2.90B |
| Dividends Payout |
|
-$7.79B | -$8.26B | -$8.77B | -$9.00B | -$9.31B |
| Capital Expenditures (Capex) |
|
-$3.07B | -$2.79B | -$3.16B | -$3.06B | -$3.32B |
| Free Cash Flow (FCF) |
|
$14.33B | $15.58B | $13.57B | $13.79B | $16.52B |
The Procter & Gamble Company Profitability
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Gross Profit |
|
$35.70B | $39.01B | $38.03B | $39.25B | $43.44B |
| Gross Profit Margin (%) |
|
50.32% | 51.25% | 47.43% | 47.86% | 51.69% |
| Operating Income |
|
$15.71B | $17.99B | $17.81B | $18.13B | $18.55B |
| Operating Income Margin (%) |
|
22.14% | 23.63% | 22.21% | 22.11% | 22.07% |
| Net Income |
|
$13.03B | $14.31B | $14.74B | $14.65B | $14.88B |
| Net Income Margin (%) |
|
18.36% | 18.79% | 18.38% | 17.87% | 17.70% |
| EBITDA |
|
$19.31B | $20.85B | $21.24B | $21.77B | $22.70B |
| EBITDA Margin (%) |
|
27.22% | 27.39% | 26.49% | 26.61% | 27.01% |
The Procter & Gamble Company Ratios
| Chart | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) |
|
28.00% | 30.85% | 31.64% | 31.33% | 29.59% |
| Return on Assets (ROA) |
|
10.79% | 11.99% | 12.58% | 12.13% | 12.16% |
| Debt to Equity |
|
74.63% | 68.97% | 67.60% | 73.98% | 64.55% |
| Debt to total asset |
|
28.77% | 26.81% | 26.87% | 28.64% | 26.53% |
| Enterprise value to revenue |
|
4.45 | 4.66 | 4.62 | 4.70 | 4.85 |
| Enterprise value to EBITDA |
|
16.36 | 17.00 | 17.46 | 17.72 | 17.97 |
| Enterprise value |
|
$315.92B | $354.41B | $370.86B | $385.71B | $407.92B |
| Cash to Debt |
|
50.12% | 57.43% | 53.10% | 48.68% | 61.14% |
| Tax Rate (%) |
|
17.25% | 18.52% | 17.79% | 19.70% | 20.19% |
| Payout Ratio |
|
59.79% | 57.76% | 59.49% | 61.41% | 62.58% |
